Dual Effects of Resveratrol on Cell Death and Proliferation of Colon Cancer Cells

References

• Ahmed S, Johnson K, Ahmed O, and Iqbal N: Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 29, 1031–1042, 2014.
   PubMed Web of Science ®Google Scholar
• Raskov H, Pommergaard HC, Burcharth J, and Rosenberg J: Colorectal carcinogenesis–update and perspectives. World J Gastroenterol 20, 18151–18564, 2014.
   PubMed Web of Science ®Google Scholar
• León-González AJ, Auger C, and Schini-Kerth VB: Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol 98, 371–380, 2015.
   PubMed Web of Science ®Google Scholar
• Takaoka MJ: Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). J Faculty Sci. Hokkaido Imperial University 3, 1–16, 1940.
   Google Scholar
• Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, et al.: Resveratrol: from basic science to the clinic. Cell Cycle 6, 2495–2510, 2007.
   PubMed Web of Science ®Google Scholar
• Orallo F: Trans-resveratrol: a magical elixir of eternal youth? Curr Med Chem 15, 1887–1898, 2008.
   PubMed Web of Science ®Google Scholar
• Cheng AS, Cheng YH, Chiou CH, and Chang TL: Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J Agric Food Chem 60, 9180–9187, 2012.
   PubMed Web of Science ®Google Scholar
• Goswami SK and Das DK: Resveratrol and chemoprevention. Cancer Lett 284, 1–6, 2009.
   PubMed Web of Science ®Google Scholar
• Talero E, Ávila-Roman J, and Motilva V: Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer. Curr Pharm Des 18, 3939–3965, 2012.
   PubMed Web of Science ®Google Scholar
• Gupta Subash C, Kannappan Ramaswamy, Reuter Simone, Kim Ji Hye, and Aggarwal Bharat B: Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 1215, 150–160, 2011.
   PubMed Web of Science ®Google Scholar
• Udenigwe CC, Ramprasath VR, Aluko RE, and Jones PJ: Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 66, 445–454, 2008.
   PubMed Web of Science ®Google Scholar
• Sak K: Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev 8, 122–146, 2014.
   PubMedGoogle Scholar
• Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, and Darwiche N: Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis 20, 1531–1562, 2015.
   PubMed Web of Science ®Google Scholar
• Fukui M, Yamabe N, Kang KS, and Zhu BT: Growth-stimulatory effect of resveratrol in human cancer cells. Mol Carcinog 49, 750–759, 2010.
   PubMed Web of Science ®Google Scholar
• Matesanz N, Lafuente N, Azcutia V, Martín D, Cuadrado A, et al.: Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases. J Hypertens 25, 609–618, 2007.
   PubMed Web of Science ®Google Scholar
• Peiró C, Lafuente N, Matesanz N, Cercas E, Llergo JL, et al.: High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br J Pharmacol 133, 967–974, 2001.
   PubMed Web of Science ®Google Scholar
• Vallejo S, Palacios E, Romacho T, Villalobos L, Peiró C, et al.: The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol 13, 158, 2014.
   PubMed Web of Science ®Google Scholar
• Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, et al.: Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett 297, 1–8, 2010.
   PubMed Web of Science ®Google Scholar
• Erlund I: Review of flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 24, 551–874, 2004.
   Web of Science ®Google Scholar
• Gilbert CA and Ross AH: Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 1, 1031–1038, 2009.
   Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, and Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377–1382, 2004.
   PubMed Web of Science ®Google Scholar
• Sreevalsan S and Safe S: Reactive oxygen species and colorectal cancer. Curr Colorectal Cancer Rep 9, 350–357, 2013.
   PubMedGoogle Scholar
• Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, et al.: NADPH oxidases and cancer. Clin Sci (Lond) 128, 863–875, 2015.
   PubMed Web of Science ®Google Scholar
• Roos WP and Kaina B: DNA damage-induced cell death by apoptosis. Trends Mol Med 12, 440–450, 2006.
   PubMed Web of Science ®Google Scholar
• Fernández-Capetillo O, Lee A, Nussenzweig M, and Nussenzweig A: H2AX: the histone guardian of the genome. DNA Repair (Amst) 3, 959–967, 2004.
   PubMed Web of Science ®Google Scholar
• Kang MA, So EY, Simons AL, Spitz DR, and Ouchi T: DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. Cell Death Dis 3, e249, 2012.
   PubMed Web of Science ®Google Scholar
• Nakagawa T and Guarente L: Sirtuins at a glance. J Cell Sci 124, 833–838, 2011.
   PubMed Web of Science ®Google Scholar
• Lin JN, Lin VC, Rau KM, Shieh PC, Kuo DH, et al.: Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem 58, 1584–1592, 2010.
   PubMed Web of Science ®Google Scholar
• McCord RA, Michishita E, Hong T, Berber E, Boxer LD, et al.: SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging 1, 109–121, 2009.
   PubMedGoogle Scholar
• Liu Y, Xie QR, Wang B, Shao J, Zhang T, et al.: Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics. Protein Cell 4, 702–710, 2013.
   PubMed Web of Science ®Google Scholar
• Zhang P, Tu B, Wang H, Cao Z, Tang M, et al.: Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc Natl Acad Sci USA 111, 10684–10689, 2014.
   PubMed Web of Science ®Google Scholar